BIO 2026: Indiana, biopharma investment and the Lilly effect - Pharmaceutical Technology

BioCrossroads' Vince Wong discusses how his state is looking to differentiate itself from its rivals. BioCrossroads' Vince Wong discusses how his state is looking to differentiate itself from its rivals. US states are jostling for the attention of the life science sector Image credit: [Zarko Prusac]/Shutterstock.com The US drive to onshore biopharmaceutical manufacturing has yielded billions of dollars of industry investment, raising the stakes for states wanting to attract companies to their corner of the country. The shape of that competition is given physical form at the 2026 BIO International Convention (BIO 2026) in San Diego, California, which runs from…

Source: Pharmaceutical Technology